SUNNYVALE, Calif. , Feb. 18, 2026 /PRNewswire/ -- Cepheid today announced that it has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators ...
SUNNYVALE, Calif., Sept. 29, 2020 /PRNewswire/ -- Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert® Xpress ...
The FDA has authorized its first rapid, point-of-care diagnostic for the novel coronavirus—allowing physicians in hospitals, clinics and emergency rooms to test a sample for the disease in about 45 ...
For much of last year, the coronavirus crept, undetected, across eastern Democratic Republic of Congo. Test samples had to be sent more than 1,500 kilometres from remote hospitals to the capital ...
Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases OXFORD, United Kingdom and SUNNYVALE, Calif., ...
New agreement aims to provide greater access to millions more high-quality tuberculosis (TB) tests for people living in the least developed countries where the need is most urgent. Enables the Global ...
Testing for COVID-19 is technical, expensive and complicated -- particularly in Alaska, with its remote, far-flung communities and overlapping systems of tribal and private health care. That ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results